News for 'Clinical Science'

COVID-19: Remdesivir will be available from next week

COVID-19: Remdesivir will be available from next week

Rediff.com4 May 2020

The EUA allows for Remdesivir to be distributed in the US and administered intravenously by health care providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalised with severe condition.

China's coronavirus toll crosses 550 mark, cases cross 28,000

China's coronavirus toll crosses 550 mark, cases cross 28,000

Rediff.com6 Feb 2020

Chinese officials hope the cases will come down in the coming days with more specialised hospitals being set up in Wuhan. China's ministry of science and technology said that a batch of Remdesivir, an antiviral drug, which will be put into clinical trials to test its efficiency on the novel coronavirus (2019-nCoV), is expected to arrive in China soon.

Indian-origin Cambridge academic wins top UK prize

Indian-origin Cambridge academic wins top UK prize

Rediff.com26 Mar 2010

Professor Shankar Balasubramanian has been awarded the prize, worth 10,000 pounds, for his work on Solexa sequencing, the high speed genome sequencing technology that means it is now possible to sequence a human genome for less than $10,000.

Meeting 1.35 bn vax dose target in Aug-Dec a long haul

Meeting 1.35 bn vax dose target in Aug-Dec a long haul

Rediff.com6 Aug 2021

While Covishield supplies would meet the target of 500 mn doses between August and December, it looks like Covaxin would miss the target of 400 mn unless the partner sites of Bharat Biotech ramp up very rapidly, reports Sohini Das.

Plasma therapy isn't proven treatment for COVID-19: Govt

Plasma therapy isn't proven treatment for COVID-19: Govt

Rediff.com29 Apr 2020

Addressing a press briefing, health ministry Joint Secretary Lav Agarwal said currently there are no approved therapies for COVID-19 and there is not enough evidence to claim that plasma therapy can be used for treatment of the disease.

'We have done our best, far earlier compared to the rest of the world'

'We have done our best, far earlier compared to the rest of the world'

Rediff.com22 Apr 2020

'On January 17, we had our first meeting with the Cabinet secretary.' 'Different secretaries belonging to different departments attended it.' 'It was only two weeks when China had said there is a new disease.' 'So, we gave the quickest response.'

Unplanned vaccination can promote mutant strains: Experts to PM

Unplanned vaccination can promote mutant strains: Experts to PM

Rediff.com10 Jun 2021

A group of public health experts, including doctors from All India Institute of Medical Sciences and members from the national taskforce on COVID-19, have said that mass, indiscriminate and incomplete vaccination can trigger emergence of mutant strains and recommended that there is no need to inoculate those who had documented coronavirus infection.

Women can get Covid vaccine anytime after delivery: Experts

Women can get Covid vaccine anytime after delivery: Experts

Rediff.com23 May 2021

"Pregnancy doesn't increase the risk of acquiring SARS-COV-2 infection but appears to worsen the clinical course as compared to non-pregnant women'

Travel restrictions imposed after 1st coronavirus death in US

Travel restrictions imposed after 1st coronavirus death in US

Rediff.com1 Mar 2020

Vice President Mike Pence said Trump had authorised a ban on entry of foreign nationals who travelled to Iran in the last 14 days. The United States also advised its citizens not to travel to parts of South Korea and Italy, from where reports of coronavirus have appeared.

COVID-19: Centre asks these 4 states to pull up socks

COVID-19: Centre asks these 4 states to pull up socks

Rediff.com18 Jul 2020

With these states imposing lockdowns anew, the health ministry emphasised that the restrictions should be utilised to focus on containment, surveillance and testing in the containment and buffer zones as the key strategy for early detection of cases and fatality management.

'Jackfruit flour may control diabetes'

'Jackfruit flour may control diabetes'

Rediff.com28 Oct 2020

'The group having rice flour and wheat flour showed an increase in glycosylated haemoglobin (HbA1c), and the group that took the jackfruit flour had a significant decrease in HbA1c.' 'Our results showed a decrease in fasting blood glucose (FBG) and postprandial glucose (PPG) after the green jackfruit flour meal.'

Covid vaccine: Too early to say if booster dose needed

Covid vaccine: Too early to say if booster dose needed

Rediff.com30 Apr 2021

Initial data has shown immunity triggered by the two mRNA vaccines -- Pfizer-BioNTech and Moderna -- lasts for at least six months

'Famotidine may become the next HCQ for Covid-19'

'Famotidine may become the next HCQ for Covid-19'

Rediff.com10 May 2020

Researchers at Northwell Health in New York are testing the effects on Famotidine (used in high intravenous doses) on Covid-19 patients as a potential treatment. After the hospital announced its clinical trials, it led to a drug shortage in the US. Back home, however, there has not been any surge in the demand for Famotidine yet.

India's Omicron count reaches 220, more states report 1st cases

India's Omicron count reaches 220, more states report 1st cases

Rediff.com21 Dec 2021

Jammu and Kashmir and Odisha on Tuesday recorded their first cases of the Omicron variant of COVID as the count of the new strain in 14 states and union territories crossed 200 even as the Centre said there is a need to 'activate' war rooms, take 'pro-active' action and consider night curfews.

UGC issues guidelines for reopening colleges, varsities

UGC issues guidelines for reopening colleges, varsities

Rediff.com6 Nov 2020

Following a six-day schedule, reducing class size, setting up isolation facilities on campus, and COVID-19 screening of students, faculty and staff are among the guidelines announced by the University Grants Commission (UGC) for reopening of universities and colleges closed since March in view of the pandemic.

COVID-19 vaccine by Oct-Nov: Serum Institute CEO

COVID-19 vaccine by Oct-Nov: Serum Institute CEO

Rediff.com22 Jul 2020

Poonawalla, during an interaction with Odisha Chief Minister Naveen Patnaik through a video conference, expressed optimism that the COVID-19 vaccine could be ready by October-November this year and the next phase of the trial can start in mid-August in India. According to a press note released by the CMO, Poonawalla has informed that the Oxford University vaccine has shown promising results in the first phase trial.

Patanjali can sell Coronil but not as cure to COVID-19: AYUSH

Patanjali can sell Coronil but not as cure to COVID-19: AYUSH

Rediff.com1 Jul 2020

The company claimed that the AYUSH ministry has "categorically agreed" that Patanjali had "appropriately worked on COVID-19 management".

7 MYTHS about infertility

7 MYTHS about infertility

Rediff.com16 Feb 2021

As unique as every child is born, and as unique are the two individuals who conceive it -- every fertility journey has its own unique features.

GSK may double headcount

GSK may double headcount

Rediff.com12 Apr 2005

GlaxoSmithKline Pharmaceuticals Limited is expanding its clinical trial data management, analyses and reporting activities in India where it plans to double the headcount depending on business needs.

The Poverty Puzzle

The Poverty Puzzle

Rediff.com7 Nov 2019

There's no silver bullet to get rid of poverty, says Alok Sheel.

Govt allows round-the-clock vaccination against COVID-19

Govt allows round-the-clock vaccination against COVID-19

Rediff.com4 Mar 2021

Easing restrictions, all private hospitals were on Tuesday allowed to give the vaccines if they adhere to the laid down norms, while the 9 am to 5 pm timing was also done away with.

How IITs are gearing up to fight COVID-19 menace

How IITs are gearing up to fight COVID-19 menace

Rediff.com31 Mar 2020

While some researchers are developing prototypes for ventilators to overcome their shortage, others have teamed up to develop testing kits.

US: First batch of COVID-19 vaccine roll out of Pfizer plant

US: First batch of COVID-19 vaccine roll out of Pfizer plant

Rediff.com14 Dec 2020

The vaccine arrives at a critical moment for the US. Hospitalisations due to COVID-19 hit record highs for the seventh day in a row on Saturday.

US authorizes Pfizer's COVID vaccine for emergency use

US authorizes Pfizer's COVID vaccine for emergency use

Rediff.com12 Dec 2020

According to The New York Times, this move means that many highly vulnerable people will begin receiving the vaccine within days. It further called the authorisation by the FDA as a 'historic turning point' as the US death toll from the Wuhan-originated virus nears 300,000.

Specialise in epidemiology

Specialise in epidemiology

Rediff.com10 Jul 2006

Tata Memorial Hospital, Mumbai, invites applications for its Master's Course in Epidemiology and Clinical Research in Oncology.

How yoga can help the elderly

How yoga can help the elderly

Rediff.com3 Jan 2020

'If the meditative yoga programme we had developed for the elderly was practised for one hour every day, five days in a week for six months, it could lead to an improvement in the overall quality of life of the elderly.'

WHO chief scientist lauds India for keeping COVID-19 count low

WHO chief scientist lauds India for keeping COVID-19 count low

Rediff.com11 May 2020

Speaking on the National Technology Day, Swaminathan said, "I would like to commend and congratulate the minister and colleagues for having contained so far the COVID pandemic in India and having kept both the number of cases and the number of deaths very low compared to other countries."

Innovative field research in India helped Abhijit Banerjee and Esther Duflo win Economics Nobel

Innovative field research in India helped Abhijit Banerjee and Esther Duflo win Economics Nobel

Rediff.com14 Oct 2019

This year's Laureates have shown how the problem of global poverty can be tackled by breaking it down into a number of smaller - but more precise - questions at individual or group levels, he Royal Swedish Academy of Sciences said.

India's children may get 2 Covid vaccines by December

India's children may get 2 Covid vaccines by December

Rediff.com28 Jun 2021

While Bharat Biotech's Covaxin is in trials among children already, Serum Institute of India will begin Novavax vaccine trials on children from July, whereas the Pfizer vaccine has been approved for adolescents in the United States; and Cadila Healthcare's ZyCoV-D has done trials on 12 year-olds and above already, reports Sohini Das.

Soon, 'Life Box' will deliver hearts for transplant by drones

Soon, 'Life Box' will deliver hearts for transplant by drones

Rediff.com23 Jun 2018

The new device, building by a team of Indian Institute of Science, Bengaluru, will keep the heart in good condition for about eight hours.

How parents enabled Covid vax trials for children

How parents enabled Covid vax trials for children

Rediff.com15 Nov 2021

Behind each Covid vaccine are hundreds of parents, who had the courage and conviction to come forth with their children for the trial of a vaccine which was, until then, untried in that age group, reports Sindhu Bhattacharya.

Jayalalithaa making gradual progress, will require longer hospitalisation

Jayalalithaa making gradual progress, will require longer hospitalisation

Rediff.com6 Oct 2016

Jayalalithaa was admitted to Apollo Hospital on September 22.

IIT to soon produce doctors

IIT to soon produce doctors

Rediff.com22 Jun 2015

IIT Kharagpur set to be a one-stop-shop for all your parents' 'doctor-engineer' dreams! :-)

Oxygen crisis: 25 Covid patients die at Delhi hospital in last 24 hrs

Oxygen crisis: 25 Covid patients die at Delhi hospital in last 24 hrs

Rediff.com23 Apr 2021

"Lives of another 60 'sickest' patients at risk. Major crisis likely," he said.

Better to address fungal infections by name than colour: AIIMS chief

Better to address fungal infections by name than colour: AIIMS chief

Rediff.com24 May 2021

The official said in general, there are various types of fungal infections such as candida, aspergillosis, cryptococcus, histoplasmosis and coccidioidomycosis. Mucormycosis, candida and aspergillosis are the ones observed more in those with low immunity, he said.

Top doctor says Japan must keep state of emergency

Top doctor says Japan must keep state of emergency

Rediff.com28 Apr 2020

'Without vaccine, Tokyo Olympics in 2021 is difficult'

Covid suspect's body to be handed over sans test: Govt

Covid suspect's body to be handed over sans test: Govt

Rediff.com15 Jun 2020

The ministry on Sunday wrote to the Delhi government, saying the bodies of suspected COVID-19 cases should be handed over to their relatives without waiting for laboratory confirmation but the mortal remains should be treated as per the government guidelines.

Haryana minister Anil Vij given trial dose of indigenous vaccine

Haryana minister Anil Vij given trial dose of indigenous vaccine

Rediff.com20 Nov 2020

The third phase trial of Bharat Biotech's Covaxin began in the state on Friday and the 67-year old senior Bharatiya Janata Party leader was administered the trial dose at the Civil Hospital at Ambala Cantt.

Wuhan wet market may not be birthplace of COVID-19: Chinese researchers

Wuhan wet market may not be birthplace of COVID-19: Chinese researchers

Rediff.com27 May 2020

The results of the study, being published on the website of top academic journal Nature on May 20, implied the Huanan Seafood Market in Hubei's capital Wuhan may not be the birthplace of COVID-19, although the virus outbreak emerged in Wuhan had a strong link to contacts with the market.

Japan, eyeing Olympics, lines up half-billion doses of COVID-19 vaccine

Japan, eyeing Olympics, lines up half-billion doses of COVID-19 vaccine

Rediff.com28 Aug 2020

Some critics contend that Japan's rush to secure supplies is driven largely by a political desire to show the world it is fully committed to hosting the Games.